NSE: HINDUNILVR· FMCGCore · Aug 26Large cap

Hindustan Unilever

Broadest lever on the volume recovery

Last close
₹1,863.80
29 Sept 2026 · reference
1D · 1M
−1.7% · −7.3%
price-only
Weight
3.3%
31 Jul 2026 · Aug rank 9
Thesis review
8 Sep 2026
Why We Own, p32
Coverage owner: Research (per book); latest results Q Jun-26Screener ↗Tijori ↗NSE ↗
Map

What must happen → what could break it → what we watch

Catalysts · 3
  • Q2FY27 results (late Oct-2026): first quarter fully lapping GST 2.0 base effects; watch for UVG holding at 5%+ and margin recovery from pricing actions.
    C1
  • Kwality Wall's open offer by Magnum Ice Cream Co consortium (26% of voting capital) post 16-Feb-2026 listing - completion cleans up HUL's portfolio narrative.
    C2
  • Festive-season demand (Oct-Nov 2026) supported by state cash transfers and lower GST; interim dividend typically announced with Q2 results.
    C3
Material risks · 3
  • Commodity inflation: 8-10% material cost inflation in Q1FY27 (palm oil, crude derivatives) with management expecting 2-5% sequential inflation and only 'calibrated' pricing - EBITDA margin risk to the 22.7% FY27E.
    R1
  • Personal Care (largest legacy segment) grew only 4% USG in Q1FY27 and is losing share to small/regional players that NIQ shows outgrowing large manufacturers.
    R2
  • Structural growth ceiling: 5-yr sales CAGR only 6.5% (screener); at 42x forward PE, any slippage back to low-single-digit volumes drives further de-rating (stock already -13% from May-26 levels).
    R3
Live monitors
  • Valuation vs approved target
    No target stated
  • Latest reported quarter
    Q Jun-26
  • Results-driven thresholds
    Awaiting approved numbers

Catalysts and risks are the approved one-pager text in full; the register below adds owners and review dates. Monitors read from the price and fundamentals feeds.

Risks as a decision framework

Material risks

Risk register
#Risk (approved text)Owner · next review
01Commodity inflation: 8-10% material cost inflation in Q1FY27 (palm oil, crude derivatives) with management expecting 2-5% sequential inflation and only 'calibrated' pricing - EBITDA margin risk to the 22.7% FY27E.Research · post 2QFY27
02Personal Care (largest legacy segment) grew only 4% USG in Q1FY27 and is losing share to small/regional players that NIQ shows outgrowing large manufacturers.Research · post 2QFY27
03Structural growth ceiling: 5-yr sales CAGR only 6.5% (screener); at 42x forward PE, any slippage back to low-single-digit volumes drives further de-rating (stock already -13% from May-26 levels).Research · post 2QFY27

Exposure mechanism, impact and mitigants are as written in the book. Leading indicators and numeric triggers not stated in the approved text remain research tasks rather than being invented.

Catalysts

Observable events

  • 01Q2FY27 results (late Oct-2026): first quarter fully lapping GST 2.0 base effects; watch for UVG holding at 5%+ and margin recovery from pricing actions.
  • 02Kwality Wall's open offer by Magnum Ice Cream Co consortium (26% of voting capital) post 16-Feb-2026 listing - completion cleans up HUL's portfolio narrative.
  • 03Festive-season demand (Oct-Nov 2026) supported by state cash transfers and lower GST; interim dividend typically announced with Q2 results.
Monitors

Live monitors from available data

  • ClearValuation exceeding the approved range: reference close 1,864 vs base target not stated.
  • DataLatest reported quarter in fundamentals: Q Jun-26. Results-driven monitors (growth below thesis threshold, margin, credit cost) need approved numeric thresholds; none in the book.
  • DataInput-cost and capital-allocation monitors require licensed commodity/filings feeds — not configured.